Close Menu

BIO5 Institute

NEW YORK (GenomeWeb News) – Danaher this week said that its board of directors has approved a quarterly dividend of $.025 per share payable on Oct. 28, to shareholders of record on Sept. 30.

Upcoming events

Upcoming Events

Upcoming Events

Lai Named SVP of R&D at Gen-Probe, Jorge Leon Joins ParagonDx SAB, Strategic Diagnostics Hires Two Execs, and More.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.